SEATTLE, March 5, 2009 – Garvey Schubert Barer is pleased to announce that Carla DewBerry, an owner in the firm’s Seattle office, has been appointed to the Benaroya Research Institute’s Board of Directors.
“Carla’s experience in financial and legal matters brings a unique perspective to BRI’s board,” said Gerald Nepom, Director of the institute. “With her and the other board members’ guidance, BRI will continue to be a leader in scientific innovation and advancement that improves lives.”
Ms. DewBerry is an experienced healthcare lawyer. Her practice emphasizes regulatory compliance and investigations, regulatory defense representation and general corporate law. In 2007 she was recognized as a Best Lawyer in America in healthcare law.
About the Benaroya Research Institute
Founded in 1956, the Benaroya Research Institute at Virginia Mason is an international leader in immune system and autoimmune disease research, transplanting discoveries to real-life applications. BRI is one of only a handful of research institutes in the word discovering causes and cures to eliminate diseases such as Type 1 diabetes, multiple sclerosis, arthritis and many others. For more information, visit www.benaroyaresearch.org.